| General Information of Drug Metabolite (DM) (ID: DM019426) |
| DM Name |
Minium ion intermediate
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Metabolizing This DM |
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Masitinib |
DR3536
|
Phase 3 |
Amyotrophic lateral sclerosis |
|
|
| References |
| 1 |
Corrigendum to: Physiologically-based pharmacokinetic modeling to evaluate in vitro-to-in vivo extrapolation for intestinal P-glycoprotein inhibition
|
| 2 |
Transient and resident pathogens: Intra-facility genetic diversity of Listeria monocytogenes and Salmonella from food production environments
|
| 3 |
IgG and IgM Immunohistochemistry in Primary Biliary Cholangitis (PBC) and Autoimmune Hepatitis (AIH) Liver Explants
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.